Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (63 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026



Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Why I am so bullish about Theralase.
View:
Post by vestor111 on Jul 15, 2020 10:30am

Why I am so bullish about Theralase.

I have been rightly accused of being a TLT bull.   Not hidding that - it should be obvious.   So why?   Why be so bully?  Well it is for one major good reason...

One of the biggest reasons I am so optimistic needs a little background first

The lab and animal studies showed overwhelming good results at TLD-1433's deadly activation. 

This research was not in a vacuum, Dr Sherri and her team first simulated thousands of compounds and then whittled that down to a hand full for more expensive and time consuming lab tissue testing.  

With that group further whittled down in the lab, the doc  and her team moved to even more time consuming and expensive lab animal models. 

 The research that was done was very extensive and reduced the final set to one compound that proved superior to the others.   The others worked but not as good as 1433.

Where the rubber meets the road...

The biggest hurdle was yet to come; how would it fair in human testing. 

Along this route the compound was shown to be very stable, water and therefore blood solutable - two very critical issues. The stablity also showed up in the shelf life studies.

BUT BY FAR, the biggest issue that won me over was binding with Transferrin.  

Transferrin has a very simple "lock and key" mechanism brought down by millions of years of evolution.   It is the exact same "lock and key" mechanism that delivers it directly to cancer's doorstep (like an Uber driver delivering food to a ravenous mob).  Directly to the transferrin recptors that cancer has 16 to 20 times more of...essentially all cancers!

This lock and key mechanism allows Rutherrin (or more precise 1433 sans the transferrin uber driver) to be welcomed right into cancer cells.   No long absorption and no complex facilitators like HCQ is with Zinc - right in the door.

RIGHT IN THE FRONT DOOR - it is even better than a "Trojan Horse" because Troy had suspicious guards guarding the wall that poked and probed the gift.  Not 1433, they have the keys to the front door and this assassin just walks right in to a hungry mob that processes it immediately.  Iron is that critical to cancer (thus the 16 to 20 times number of receptors than healthy cells.)

THAT is no small potatoes folks - that is the most elegant solution to cancer every devised in this war that has raged for untold millennia.

That's why I am so bullish.  The rest is to satisfy bureaucrats and their processes (necessary by-in-large but plodding). 

Add on top of this a new process - the ever changing, often seat of the pants rules and regs that often change almost daily (at least in the states) over the C-19 scare.  And all of this takes time.   AND IT IS ALL OUT OF THE MANAGEMENT'S HANDS!

So while they could communicate better (like posting the RPCCC study - even if the RPCCC device appears to compete directly with TLT's device winding through the patent office), they too are probably waiting for the call from "the process."

And let's forget to overstate or state too early the unknown can be perilous.
Don't forget - this company was flogged by bureaucrats for overstating things. So why ask for another flogging?

So we wait...but TLT and Dr Sherri have a compound with the "lock and key" solution - riding a taxi right to cancer's door with keys in hand - welcomed in.  Deadly food - with the incredible add bonus of waking up the immune system.   BANG! 

It is hard to poke a hole in this or come up with a more elegant solution.

Activation will have its challenges but solving those challenges will only make TLT more valuable to the world.

GLTA LONGS!
Comment by vestor111 on Jul 15, 2020 10:41am
Got done and saw the price - YES bought more!
Comment by tomchoco on Jul 15, 2020 11:17am
I wish TLT had someone like you working to promote the company. You have become the number 1 poster on this board.
Comment by Hankerchief on Jul 15, 2020 11:53am
Nicely done Ves tor.  regarding "Activation" it may become very easily done with Xray?   Eliminates cutting and drilling holes.  Just need an IV + Rutherrin + Xray.......easy.  Why isn't this being done?
Comment by vestor111 on Jul 15, 2020 1:00pm
Thx and Yes indeed and very low power X-rays at that.  I assume more research is ongoing and hopefully we will hear more in the coming months. 
Comment by Pandora on Jul 15, 2020 1:25pm
  Imagin to test i/Blue on anatomical bladder models   2020-07-15 12:42 ET - News Release   Mr. Jim Hutchens reports IMAGIN MEDICAL TO BEGIN TESTING OF I/BLUE IMAGING SYSTEM ON ANATOMICAL BLADDER MODELS Imagin Medical Inc. will begin testing the i/Blue imaging system using anatomical bladder models to confirm simultaneous white-light and blue-light image display ...more  
Comment by Bunge on Jul 15, 2020 12:52pm
Someone take away Roger's $200G/yr salary and give it to this man.
Comment by goldn1 on Jul 15, 2020 2:37pm
Vestorr: We all hope you are right, but knowing TLT, I can't imagine things will go as smooth as you envision... G1
Comment by Quattro74 on Jul 15, 2020 7:36pm
The ONLY thing I can imagine not going smoothly in the future is the next financing. Assuming we will need one at some point. I think all the really bad stuff is behind TLT now. I think the trial(s) will go smoothly assuming the docs running them know their business.
Comment by goldn1 on Jul 16, 2020 10:31am
Quattro: If TLT "has the goods" and can prove it, financing won't b a problem, ppl will be running to them w money. But they need to prove they are on the right track and, imo, they haven't convinced any institutional or large investment firms. You would think the "investor conference" 9 months ago had a purpose, but it doesn't look like they have the big buyers as ...more  
Comment by Quattro74 on Jul 16, 2020 10:44am
Hey I agree Goldie, would love to see some phase 2 data. They need to throw us a bone. FT or BT designations would also be a nice PR opportunity. Like you say the BIG buyers will come running with $$$ ka-ching! once TLT proves it has something. 2 for 2 CR for 18 months was a nice phase 1 but too small a sample size for wall street.
Comment by vestor111 on Jul 16, 2020 10:49am
Woof Woof! 
Comment by Hempdoc on Jul 16, 2020 5:52pm
  Hey G1... For this particular indication/unmet need, I believe we already have enough for a fast track designation, which preferably/generally takes place during the IND phase of drug development.  The reason for early filing of an application is to not only expedite the review process, but also it is encouraged by the FDA to facilitate efficient drug development in a "timely ...more  
Comment by investclub on Jul 16, 2020 6:16pm
Thanks Hempdoc your thoughts & corrections are always appreciated 
Comment by skyhawk1 on Jul 16, 2020 10:06am
  EXCELLENT POST ~ V! SUMS UP THE TLT STORY & "WHY" WE SUPER LONGS R HERE HOLDING MILLIONS ~ VERY TIGHT & STEADFAST!! G'day ya'll  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 63 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     


Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250